Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence
Authors:
- 13 July 2022
- journal article
- research article
- Published by Springer Nature in Behavior Analysis in Practice
- Vol. 16 (2) , 450-458
Abstract
Buprenorphine is an important medication for treating opioid use disorder, but medication adherence and treatment retention are key issues that can limit its impact, especially when patients have concurrent stimulant use. Contingency management is efficacious in promoting medication adherence and drug abstinence. Delivering contingency management via smartphones addresses practical barriers to its adoption and improves patient access. A single-group (n = 20) nonexperimental study was conducted to evaluate the feasibility of smartphone-based contingency management to promote adherence to buprenorphine treatment in people with opioid use disorder. Participants were recruited from outpatient treatment clinics. Over 12 weeks participants had access to a smartphone app that provided contingency management supported with peer recovery coaching. Adherence was confirmed daily either by GPS monitoring of clinic medication visits or self-recorded video, and salivary toxicology was conducted weekly. The overall rate of confirmed buprenorphine adherence was 76%, and visual inspection of individual participant outcomes shows consistent medication use for a large majority of participants. All participants were able to successfully use all app features and spend earnings. Participants rated the app and intervention highly on measures of likability, ease of use, and helpfulness. All participants (100%) were retained in buprenorphine treatment throughout the study period. Direct methods for confirming adherence appear superior to confirmation via salivary toxicology. This study shows that smartphone-based contingency management is a feasible means of promoting buprenorphine adherence. The potential efficacy of smartphone-based contingency management as a means of promoting buprenorphine adherence warrants evaluation in a randomized controlled trial.Keywords
This publication has 36 references indexed in Scilit:
- Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trialDrug and Alcohol Dependence, 2012
- Enabling or Engaging? The Role of Recovery Support Services in Addiction RecoveryAlcoholism Treatment Quarterly, 2010
- Nonclinical Addiction Recovery Support Services: History, Rationale, Models, Potentials, and Pitfalls1Alcoholism Treatment Quarterly, 2010
- Effect of Directly Observed Therapy for Highly Active Antiretroviral Therapy on Virologic, Immunologic, and Adherence Outcomes: A Meta-Analysis and Systematic ReviewJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- A Meta-Analytic Review of Psychosocial Interventions for Substance Use DisordersAmerican Journal of Psychiatry, 2008
- Contingency management for treatment of substance use disorders: a meta‐analysisAddiction, 2006
- A meta‐analysis of voucher‐based reinforcement therapy for substance use disordersAddiction, 2006
- The duration and correlates of addiction and treatment careersJournal of Substance Abuse Treatment, 2005
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence2003
- Drug Addiction, Dysregulation of Reward, and AllostasisNeuropsychopharmacology, 2001